Cargando…

Effect of Dolutegravir regimen against other regimens on some hematological parameters, CD4 count and viral load of people living with HIV infection in South Eastern Nigeria

BACKGROUND: Appropriate usage of highly active antiretroviral therapy (HAART) suppresses human immunodeficiency virus (HIV) replication. One of such HAART is dolutegravir (DTG) containing regimen which Nigeria included in her national protocol, as the preferred first-line option, with particularly f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Echefu, Stella N., Udosen, Joseph E., Akwiwu, Euphoria C., Akpotuzor, Josephine O., Obeagu, Emmanuel Ifeanyi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	4850
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10681510/ https://www.ncbi.nlm.nih.gov/pubmed/38013350 http://dx.doi.org/10.1097/MD.0000000000035910

Ejemplares similares

Real life use of dolutegravir doravirine dual regimen in experienced elderly PLWH with multiple comorbidities and on polypharmacy: A retrospective analysis
por: Mazzitelli, Maria, et al.
Publicado: (2021)

Regulations of malaria in children with human immunodeficiency virus infection: A review
por: Opeyemi, Abdulrahman Abdulbasit, et al.
Publicado: (2023)

First-line cART regimen impacts the course of CD8(+) T-cell counts in HIV-infected patients that achieve sustained undetectable viral load.
por: Poizot-Martin, Isabelle, et al.
Publicado: (2016)

Comparative Effectiveness of First Antiretroviral Regimens in Clinical Practice Using a Causal Approach
por: Cuzin, Lise, et al.
Publicado: (2015)

Comparative effectiveness of single versus multiple tablet antiretroviral therapy regimens in clinical HIV practice
por: Drozd, Daniel R., et al.
Publicado: (2017)

Durability of non-nucleotide reverse transcriptase inhibitor-based first-line ART regimens after 7 years of treatment in rural Uganda: A prospective cohort study
por: Nanfuka, Mastula, et al.
Publicado: (2021)

Dolutegravir plus rilpivirine: benefits beyond viral suppression: DORIPEX retrospective study
por: Troya, Jesús, et al.
Publicado: (2022)

Tolerability and effectiveness of albuvirtide combined with dolutegravir for hospitalized people living with HIV/AIDS
por: Liu, Huanxia, et al.
Publicado: (2023)

Meta-Analysis of Studies Comparing Single and Multi-Tablet Fixed Dose Combination HIV Treatment Regimens
por: Clay, P.G., et al.
Publicado: (2015)

Two case reports of severe myocarditis associated with the initiation of dolutegravir treatment in HIV patients
por: Mahlab-Guri, Keren, et al.
Publicado: (2016)

Comparative Impact of Suppressive Antiretroviral Regimens on the CD4/CD8 T-Cell Ratio: A Cohort Study
por: Masiá, Mar, et al.
Publicado: (2016)

Impact of switching to tenofovir alafenamide on weight gain as compared to maintaining a non-tenofovir alafenamide containing regimen
por: Darnell, Julia, et al.
Publicado: (2021)

The efficacy and safety of tenofovir alafenamide versus tenofovir disoproxil fumarate in antiretroviral regimens for HIV-1 therapy: Meta-analysis
por: Wang, Huilian, et al.
Publicado: (2016)

Efavirenz versus boosted atazanavir-containing regimens and immunologic, virologic, and clinical outcomes: A prospective study of HIV-positive individuals
por: Cain, Lauren E., et al.
Publicado: (2016)

Safety of low dose efavirenz regimen in Indian adults with HIV-1 infection: Insights from a phase 4 interventional randomised trial
por: Dravid, Ameet N., et al.
Publicado: (2023)

Case report of Triumeq (abacavir/dolutegravir/lamivudine) associated rhabdomyolysis in a human immunodeficiency virus (HIV) infected patient
por: Saad, Muhammad, et al.
Publicado: (2019)

Strategic use of dual regimens of boosted protease inhibitors plus maraviroc in poorly adherent subjects in view of long-acting drugs: A retrospective study
por: Capetti, Amedeo Ferdinando, et al.
Publicado: (2017)

Long-term efficacy and toxicity of abacavir/lamivudine/nevirapine compared to the most prescribed ARV regimens before 2013 in a French Nationwide Cohort Study
por: de Boissieu, Paul, et al.
Publicado: (2016)

Viral suppression in the era of transition to dolutegravir-based therapy in Cameroon: Children at high risk of virological failure due to the lowly transition in pediatrics
por: Fokam, Joseph, et al.
Publicado: (2023)

Impact of previous HIV resistance and virologic failures on virologic outcome following a switch to dolutegravir with 2 NRTIs among people living with HIV
por: Sangaré, Mohamed N’dongo, et al.
Publicado: (2020)

Real-world efficacy and safety of dolutegravir plus lamivudine versus tenofovir plus lamivudine and efavirenz in ART-naïve HIV-1-infected adults
por: Li, Jin, et al.
Publicado: (2022)

A real-world, cross sectional study of oral lesions and their association with CD4 cell counts and HIV viral load in Yunnan, China
por: Shu, Wen, et al.
Publicado: (2020)

High levels of virological failure with major genotypic resistance mutations in HIV-1-infected children after 5 years of care according to WHO-recommended 1st-line and 2nd-line antiretroviral regimens in the Central African Republic: A cross-sectional study
por: Mossoro-Kpinde, Christian Diamant, et al.
Publicado: (2017)

Elevated CD8 T-cell counts and virological failure in HIV-infected patients after combination antiretroviral therapy
por: Ku, Nam Su, et al.
Publicado: (2016)

Effects of Rational-Emotive Health Education Program on HIV risk perceptions among in-school adolescents in Nigeria
por: Onyechi, Kay Chinonyelum Nwamaka, et al.
Publicado: (2016)

Age and CD4(+) T cell counts are inversely associated with HIV drug resistance mutations in treatment naive female sex workers
por: Mulinge, Martin M., et al.
Publicado: (2023)

Prevalence and correlates of chronic kidney disease (CKD) among ART-naive HIV patients in the Niger-Delta region of Nigeria
por: Ekrikpo, Udeme E., et al.
Publicado: (2018)

Age, absolute CD4 count, and CD4 percentage in relation to HPV infection and the stage of cervical disease in HIV-1-positive women
por: Chambuso, Ramadhani, et al.
Publicado: (2020)

Association between serum amylase levels and CD4 cell counts in newly diagnosed people living with HIV: A case-control study
por: Jin, Yong, et al.
Publicado: (2023)

CD4/CD8 ratio and CD8 counts predict CD4 response in HIV-1-infected drug naive and in patients on cART
por: Sauter, Rafael, et al.
Publicado: (2016)

Comparative effects of 6-weeks progressive resistance exercise and moderate intensity aerobic exercise on CD4 count and weights of people living with HIV/AIDS in Alex-Ekwueme Federal University Teaching Hospital Ebonyi State
por: Asogwa, Eucharia Ijego, et al.
Publicado: (2022)

Advancing research for HIV prevention among African, Caribbean and Black men: Protocol for a multisite cross-sectional study in Ontario (weSpeak study)
por: Husbands, Winston, et al.
Publicado: (2021)

Liver fibrosis progression and clinical outcomes are intertwined: role of CD4+ T-cell count and NRTI exposure from a large cohort of HIV/HCV-coinfected patients with detectable HCV-RNA: A MASTER cohort study
por: Focà, Emanuele, et al.
Publicado: (2016)

Real-World Experience with Dolutegravir-Based Two-Drug Regimens
por: Ward, Douglas, et al.
Publicado: (2020)

Neurocognitive development in HIV-positive children is correlated with plasma viral loads in early childhood
por: Weber, Valentin, et al.
Publicado: (2017)

Sensitivity and specificity of dried blood spots for HIV-1 viral load quantification: A laboratory assessment of 3 commercial assays
por: Pannus, Pieter, et al.
Publicado: (2016)

Should viral load thresholds be lowered?: Revisiting the WHO definition for virologic failure in patients on antiretroviral therapy in resource-limited settings
por: Labhardt, Niklaus D., et al.
Publicado: (2016)

Differences in human immunodeficiency virus-1C viral load and drug resistance mutation between plasma and cerebrospinal fluid in patients with human immunodeficiency virus-associated cryptococcal meningitis in Botswana
por: Kelentse, Nametso, et al.
Publicado: (2020)

1009. Dolutegravir and Doravirine in Combination: When Standard Antiretroviral Regimens are Unacceptable
por: Denyer, Rachel, et al.
Publicado: (2020)

Neurocognitive improvement in HIV-positive patients treated with dolutegravir-based regimens
por: Rodrigues, Janine, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_nsci6dhr1epk1acegmtslmo4sb